New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 30, 2014
07:45 EDTMDSOMedidata Solutions price target raised to $55 from $47 at Stifel
Stifel increased its price target on Medidata as the firm thinks the company has a strong platform and robust analytics. The firm believes the company has a number of other positive catalysts and is well-positioned to deliver strong growth. Stifel expects the company to report favorable Q2 results and keeps a Buy rating on the shares.
News For MDSO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
08:33 EDTMDSOMedidata cloud platform selected by Cancer Research UK
Medidata and Cancer Research UK announced that the Medidata Clinical Cloud has been selected to support the charity’s drug discovery research.
March 24, 2015
07:04 EDTMDSOMedidata a compelling opportunity in mHealth, says Stifel
After meeting with Medidata's management, Stifel thinks the stock provides a compelling opportunity for investors looking for exposure to mobile health, or mHealth, products. The firm says that Medidata's Patient Cloud can provide previously unavailable data, and the firm thinks that the company's recently announced but unnamed platform customer may be GlaxoSmithKline.(GSK). Stifel raised its price target on Medidata to $60 from $55 and keeps a Buy rating on the shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use